QIV-HD

High-dose quadrivalent inactivated influenza vaccine · Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for QIV-HD, covering 2021-01-19 to 2023-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older [Phase 3]

See pricing